Clinical Trials Directory

Trials / Completed

CompletedNCT00213122

Effects of Miglitol on Daily Plasma Glucose in type2 Diabetes Treated With Insulin

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
Sponsor
Sanwa Kagaku Kenkyusho Co., Ltd. · Industry
Sex
All
Age
20 Years – 74 Years
Healthy volunteers
Not accepted

Summary

In this study, the effect of miglitol on daily plasma glucose will be evaluated in type 2 diabetic patients treated with insulin.

Conditions

Interventions

TypeNameDescription
DRUGmiglitol

Timeline

First posted
2005-09-21
Last updated
2006-09-28

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00213122. Inclusion in this directory is not an endorsement.